Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauryn Ruegg

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|July 14, 2025
Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate CancerAhmed M Elgehama, Qian Yang, Zaoke He, et al.
Journal of Visualized Experiments : Jove|April 14, 2025
An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell AnalysesLauryn Ruegg, Laura B James-Allan, Gabriella DiBernardo, et al.
Translational Oncology|May 17, 2026
A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical associationAhmed M Elgehama, Qian Yang, Jaceline Gislaine Pires Sanches, et al.
STAR Protocols|April 6, 2025
Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assaysYan-Ruide Li, Christopher J Ochoa, Zibai Lyu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2026
Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockadeEvan R Abt, Liang Wang, Grigor Varuzhanyan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|July 14, 2025
Identification of a RIPK2-Regulated Gene Signature as a Candidate Biomarker for RIPK2 Activity and Prognosis in Prostate CancerAhmed M Elgehama, Qian Yang, Zaoke He, et al.
Journal of Visualized Experiments : Jove|April 14, 2025
An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell AnalysesLauryn Ruegg, Laura B James-Allan, Gabriella DiBernardo, et al.
Translational Oncology|May 17, 2026
A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical associationAhmed M Elgehama, Qian Yang, Jaceline Gislaine Pires Sanches, et al.
STAR Protocols|April 6, 2025
Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assaysYan-Ruide Li, Christopher J Ochoa, Zibai Lyu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2026
Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockadeEvan R Abt, Liang Wang, Grigor Varuzhanyan, et al.
Pageof 1